Buy, Sell or Hold: Neurochem (NRM-T) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Neurochem (NRM-T)

0.00

0.00 (0.00%) 1d

COMMENT

The name of the company was indistinct and this is the closest result in the data base. It is a biotech company focused on brain health. It acquired an AI company called Metro Mark. It is signing more and more deals with pharmaceutical companies for up-front and royalty payments.

biotechnology / pharmaceutical

SELL

He likes it, the only downside is that because the Japaneese market has risen 40% over the last year, it's a bit expensive right now. He suggests going to a different fund which is not so centered on the Japaneese market.

biotechnology / pharmaceutical

DON'T BUY

Looking at his relative performer chart, it's been an underperformer. Has negative money flow. In a very clear downtrend.

biotechnology / pharmaceutical

BUY

There has been a general selloff of biotech stocks. Still believe in this company.

biotechnology / pharmaceutical

DON'T BUY

Feels it's a little pricey at these levels given where they are in the development of their program. Have some interesting programs.

biotechnology / pharmaceutical

BUY

Has been moving sideways which, for a biotech, is not too bad. The company has good backing. Should see considerable upside.

biotechnology / pharmaceutical

PAST TOP PICK

(A top pick Sept 9/03. Up100 %.) Still likes. The market opportunity is so big, would still buy at this price.

biotechnology / pharmaceutical

PAST TOP PICK

(A top pick Sept 9/03. Up 58%.) As a potential treatment for Alzheimer's. Good technology. Has some US financing which will get US investors interested.

biotechnology / pharmaceutical

TOP PICK

Into phase 3 trial. All cashed up. Will start to be getting attention.

biotechnology / pharmaceutical

BUY

Has a very strong range of products.

biotechnology / pharmaceutical

HOLD

Has gone up quite well and may stay level for awhile.

biotechnology / pharmaceutical

TOP PICK

Likes the managemnt. Big financial support.

biotechnology / pharmaceutical

Showing 1 to 12 of 12 entries

«
‹
1
›
»

Neurochem(NRM-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Neurochem is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Neurochem(NRM-T) Frequently Asked Questions

What is Neurochem stock symbol?

Neurochem is a OTC stock, trading under the symbol NRM-T on the (). It is usually referred to as or NRM-T

Is Neurochem a buy or a sell?

In the last year, there was no coverage of Neurochem published on Stockchase.

Is Neurochem a good investment or a top pick?

Neurochem was recommended as a Top Pick by on . Read the latest stock experts ratings for Neurochem.

Why is Neurochem stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Neurochem worth watching?

In the last year 0 stock analysts on Stockchase covered Neurochem. The stock is worth watching.

What is Neurochem stock price?

On , Neurochem (NRM-T) stock closed at a price of $.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.